Brookline Capital Markets Stock Recommendations and Price Targets

This is a list of recent ratings by Brookline Capital Markets.

DateCompany NameActionCurrent
Price
Price
Target
Rating
5/20/2026
PMN
Promis Neurosciences
Upgrade$9.00Strong-Buy
5/7/2026
ERNA
Ernexa Therapeutics
Initiated Coverage$8.00 $30.00Buy